4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide
C100H88F10N40O6 — CID 160514091
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide
4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide (PubChem CID 160514091) has the molecular formula C100H88F10N40O6 and a molecular weight of 2136.06 g/mol. Its IUPAC name is 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide.
Molecular Properties
| Compound Name | 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide |
|---|---|
| PubChem CID | 160514091 |
| Molecular Formula | C100H88F10N40O6 |
| Molecular Weight | 2136.06 g/mol |
| Exact Mass | 2134.77 |
| IUPAC Name | 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[[3-ethenyl-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]amino]methylideneamino]acetamide;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide |
| SMILES | C=Cc1nnc(-c2ccc(C(F)(F)F)cc2)n1N/C=N/CC(N)=O.COc1cccc(-c2nnc3ccc(NC4CC4)nn23)c1.COc1ccccc1-c1nnc2ccc(NC3CC3)nn12.N#Cc1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1.NC(=O)CNc1ccc2nnc(-c3cccc(C(F)(F)F)c3)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3C(F)(F)F)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3F)n2n1 |
| InChI | InChI=1S/C15H12N6.2C15H15N5O.2C14H11F3N6O.C14H13F3N6O.C13H11FN6O/c16-9-10-1-3-11(4-2-10)15-19-18-14-8-7-13(20-21(14)15)17-12-5-6-12;1-21-12-4-2-3-10(9-12)15-18-17-14-8-7-13(19-20(14)15)16-11-5-6-11;1-21-12-5-3-2-4-11(12)15-18-17-14-9-8-13(19-20(14)15)16-10-6-7-10;15-14(16,17)9-3-1-2-8(6-9)13-21-20-12-5-4-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-4-2-1-3-8(9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;1-2-12-21-22-13(23(12)20-8-19-7-11(18)24)9-3-5-10(6-4-9)14(15,16)17;14-9-4-2-1-3-8(9)13-18-17-12-6-5-11(19-20(12)13)16-7-10(15)21/h1-4,7-8,12H,5-6H2,(H,17,20);2-4,7-9,11H,5-6H2,1H3,(H,16,19);2-5,8-10H,6-7H2,1H3,(H,16,19);2*1-6H,7H2,(H2,18,24)(H,19,22);2-6,8H,1,7H2,(H2,18,24)(H,19,20);1-6H,7H2,(H2,15,21)(H,16,19) |
| InChIKey | QTKNWBYHZUBSIT-UHFFFAOYSA-N |
| XLogP | 12.89 |
| TPSA | 600.37 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 156 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2136.06 |
| LogP ≤ 5 | 12.89 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 41 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160514091 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.